BBC Health 10 Sep 2026
Campaigners hold vigil as stroke unit closes
Patients needing urgent care will be taken to Taunton or Dorchester instead.
10 Sep 2026
Read →
These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney…
This study aims to learn why atrial fibrillation (AF), a type of irregular heartbeat, happens more often and is harder to treat…
Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety of treatment in patients…
Heart failure and atrial fibrillation are two of the most common heart diseases globally. Nearly half of all patients with heart failure…
Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF)…
Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and cardioembolic stroke due to AF is its major complication. Direct…
Atorvastatin is a statin medicine used to lower cholesterol and reduce the risk of heart attack…
Learn more →Living with Heart & Circulation? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Heart & Circulation. Connect, share experiences, and support each other.
The latest pipeline drugs, clinical breakthroughs, and regulatory approvals from the FDA, EMA and NICE for Heart & Circulation patients.
HTG694
📋 Information sourced from clinical trial registries, FDA, EMA and published research
View all research →No podcasts available yet for Heart & Circulation
Sign up for updates below to be notified when we release a free patient podcast for this area.